
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16367406
[patent_doc_number] => 10799138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Method of administering sotalol IV/switch
[patent_app_type] => utility
[patent_app_number] => 16/376706
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 7453
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376706 | Method of administering sotalol IV/switch | Apr 4, 2019 | Issued |
Array
(
[id] => 15290411
[patent_doc_number] => 20190388341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => CHEWABLE GEL DOSAGE FORM AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/372177
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372177 | CHEWABLE GEL DOSAGE FORM AND ASSOCIATED METHODS | Mar 31, 2019 | Abandoned |
Array
(
[id] => 15144935
[patent_doc_number] => 20190350945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => USES OF OXYGENATED CHOLESTEROL SULFATES (OCS)
[patent_app_type] => utility
[patent_app_number] => 16/368553
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368553
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368553 | Uses of oxygenated cholesterol sulfates (OCS) | Mar 27, 2019 | Issued |
Array
(
[id] => 15206045
[patent_doc_number] => 20190365709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy
[patent_app_type] => utility
[patent_app_number] => 16/348630
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348630 | Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy | Mar 20, 2019 | Abandoned |
Array
(
[id] => 15524605
[patent_doc_number] => 20200054608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA
[patent_app_type] => utility
[patent_app_number] => 16/361085
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361085 | ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA | Mar 20, 2019 | Abandoned |
Array
(
[id] => 16688261
[patent_doc_number] => 20210070737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => ANTIVIRAL COMPOUNDS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/981346
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981346
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981346 | Antiviral compounds and use thereof | Mar 17, 2019 | Issued |
Array
(
[id] => 14531525
[patent_doc_number] => 20190201383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts
[patent_app_type] => utility
[patent_app_number] => 16/297006
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16297006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/297006 | Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts | Mar 7, 2019 | Abandoned |
Array
(
[id] => 14497741
[patent_doc_number] => 20190192525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => APILIMOD COMPOSITIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/289963
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289963 | APILIMOD COMPOSITIONS AND METHODS FOR USING SAME | Feb 28, 2019 | Abandoned |
Array
(
[id] => 16555685
[patent_doc_number] => 20210000833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => INHIBITION OF NSMASE FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/977309
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977309
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977309 | Inhibition of nSMase for the treatment of human immunodeficiency virus infection | Feb 28, 2019 | Issued |
Array
(
[id] => 14497619
[patent_doc_number] => 20190192464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/289214
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289214 | BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS | Feb 27, 2019 | Abandoned |
Array
(
[id] => 15813773
[patent_doc_number] => 10632043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Premix formulation for parenteral use and packaging thereof
[patent_app_type] => utility
[patent_app_number] => 16/285527
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6920
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285527
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285527 | Premix formulation for parenteral use and packaging thereof | Feb 25, 2019 | Issued |
Array
(
[id] => 14464481
[patent_doc_number] => 20190183880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => METHOD OF INHIBITING MUTANT C-KIT
[patent_app_type] => utility
[patent_app_number] => 16/283190
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283190 | Method of inhibiting mutant C-KIT | Feb 21, 2019 | Issued |
Array
(
[id] => 16761000
[patent_doc_number] => 20210106581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => Treatment Of Liver Diseases
[patent_app_type] => utility
[patent_app_number] => 16/970543
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970543 | Treatment Of Liver Diseases | Feb 18, 2019 | Abandoned |
Array
(
[id] => 16640788
[patent_doc_number] => 10918609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient
[patent_app_type] => utility
[patent_app_number] => 16/274478
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8687
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274478 | Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient | Feb 12, 2019 | Issued |
Array
(
[id] => 16619913
[patent_doc_number] => 20210038566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/967752
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967752 | USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION | Feb 7, 2019 | Abandoned |
Array
(
[id] => 14578297
[patent_doc_number] => 20190216757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Methods for Cancer and Immunotherapy Using Prodrugs of Glutamine Analogs
[patent_app_type] => utility
[patent_app_number] => 16/262476
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16262476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/262476 | Methods for cancer and immunotherapy using prodrugs of glutamine analogs | Jan 29, 2019 | Issued |
Array
(
[id] => 14336925
[patent_doc_number] => 20190150435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => MIXTURES OF SABADILLA ALKALOIDS AND PYRETHRUM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/253327
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253327 | MIXTURES OF SABADILLA ALKALOIDS AND PYRETHRUM AND USES THEREOF | Jan 21, 2019 | Abandoned |
Array
(
[id] => 16197414
[patent_doc_number] => 10722550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Compositions and methods for the treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 16/250612
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 6465
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16250612
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/250612 | Compositions and methods for the treatment of fungal infections | Jan 16, 2019 | Issued |
Array
(
[id] => 15510339
[patent_doc_number] => 10561736
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-02-18
[patent_title] => Apoptosis inhibitor formulations for prevention of hearing loss
[patent_app_type] => utility
[patent_app_number] => 16/243892
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 16878
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/243892 | Apoptosis inhibitor formulations for prevention of hearing loss | Jan 8, 2019 | Issued |
Array
(
[id] => 17844897
[patent_doc_number] => 11434249
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-09-06
[patent_title] => ASK1 inhibitor compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/958053
[patent_app_country] => US
[patent_app_date] => 2018-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42691
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958053 | ASK1 inhibitor compounds and uses thereof | Dec 30, 2018 | Issued |